期刊文献+

左西孟旦、米力农、硝普钠治疗急性心力衰竭的疗效对比 被引量:2

下载PDF
导出
摘要 目的:对比用左西孟旦、米力农、硝普钠治疗急性心力衰竭的疗效。方法 :将2014年4月至2015年1月期间在重庆市南川区宏仁医院内二科就诊的114例急性心力衰竭患者随机分为A、B、C三组,每组各有38例患者。用左西孟旦对A组患者进行治疗,用米力农对B组患者进行治疗,用硝普钠对C组患者进行治疗。治疗结束后,观察对比三组患者治疗的总有效率、并发症的发生率及心功能的改善情况。结果 :在治疗后,A组患者治疗的总有效率明显高于B、C组患者,其并发症的发生率及NT-pro BNP的水平均明显低于B、C组患者,差异具有统计学意义(P<0.05)。结论 :用左西孟旦治疗急性心力衰竭的效果明显优于用米力农或硝普钠治疗的效果。而且,用左西孟旦治疗该病可显著降低患者并发症的发生率和NT-pro BNP的水平。
作者 吴凤
出处 《当代医药论丛》 2017年第9期83-84,共2页
  • 相关文献

参考文献4

二级参考文献35

  • 1John JV.McMurray,Stamatis Adamopoutos,et al.ESC guidelines for the diagnosis and treatment of acute and chronic[J].Heart Failure,2012,2012(4):384-416.
  • 2Kopustinskiene DM,Pollesello P,Saris NE.Levosimendan is a mitochondrial KATP channel opener[J].Eur J、Pharmacology,2001,428:311-314.
  • 3Kersten JR,Montgomery MW,Pagel PS,et al.Levosimendan a new positive inotropic drug,decreases myocardial infarct size via activation of KATP channels[J].Anesth Analg,2000,90:5-11.
  • 4Toller WG,Stranz C.Levosimendan,a new inotropic and vasodilator agent[J].Anestbesiolng,2006,104:556-569.
  • 5Avgeropoulou C,Andreadou I,Markantonis-Ky roudiss,et al.The Ca2+-sensitizer Ievosimendan improves oxidative damage,BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobu-tamine[J].Eur J Heart Fail,2005,7:882-887.
  • 6Lee SCfStevens TUSandberg SM,et al.The potential of brain-natriuretic peptide as biomarker for New York Heart Association class during the outpatient treatment of heart failure[J].J Card Fail,2002,8:149-154.
  • 7Lemos J,McGuire D,Drazller Mf et al.B-type natriuretic pip-tide in cardiovascular disease[J],Lancet,2003,362:316-322.
  • 8Mebazaa A,Nieminen MS,Packer M,et al.Levosimendan Vs dobutamine for patients with acute decompensated heart fail-ture:The SURVIVE randomized trial[J].Cardiology,2007,9:9-10.
  • 9Moiseyev VS,Poder P,Andrejevs N,et al.Safety and efficacy of a novel calcium sensitizer,Ievosimendan in patients with left ventricular failure due to an acute myocardial infarction:A randomized,placebo-controlled,double-blind study(RUSSLAN)[J].Eur Heart J,2002,23:1422-1432.
  • 10Follath F,Cleland JG,Just H,et al.Efficacy and safety of intravenous Ievosimendan compared with dobutamine in severe low-output heart failure(the LIDO study):A randomized double-blind trilal[J],Lancet,2002,360:196-202.

共引文献50

同被引文献17

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部